Axel Schambach

Axel Schambach, Dr. med. and PhD, is Director of the Institute of Experimental Hematology and Professor for Gene Modification of Somatic Cells (W3) at Hannover Medical School (MHH). He studied medicine in Hamburg, San Diego, San Francisco, Dallas and Zürich received his PhD in Molecular Medicine. His main research interest is to understand the molecular pathophysiology of inborn and acquired diseases to develop tailor-made gene therapy and molecular medicine strategies. Here, he focuses on novel gene delivery tools, including state-of-the-art integrating vectors and designer nucleases as well as new reprogramming and transdifferentiation strategies and stem cell-based disease modeling.